Research: Body Positive Images on Instagram Boost Men’s Moods and Self-images
Body positive images on social media improve how men see their bodies, according to new research in Acta Psychologica. For the study, researchers examined body positive and idealized body images on Instagram and the impact they have on 207 men and women on terms of positive and negative moods, body satisfaction, drive for thinness and drive […]
“We All Need to Be Diligent Watching for Cutaneous Signs of Syphilis”
By Ted Rosen, MD The federal Centers for Disease Control and Prevention finally released 2022 US syphilis statistics, and they are abysmal. The number of syphilis cases (all stages) increased by 17.3% compared to 2021. Primary and secondary syphilis cases rose 9.3% compared to 2021. Tragically, congenital syphilis cases totaled 3,755 representing an astonishing 31% […]
With Investment in Acorn Biolabs, Merz Aesthetics Continues to Double Down on Commitment to Advancing Regenerative Aesthetics
Merz Aesthetics is investing in Acorn Biolabs by leading its Series A funding round. Acorn Biolabs is a personalized regenerative medicine company with offices in Toronto, Canada and Los Angeles. U.S. Acorn Biolabs offers a non-invasive, follicle-based, stem cell cryopreservation service for therapeutic and aesthetic applications and is developing treatments made from a client’s own […]
BTL Takes on Double Chins With New EMFACE Applicator
BTL is rolling out the new EMFACE Submentum applicator. The new EMFACE Submentum applicator applies a patented combination of Synchronized Radiofrequency and the high-intensity focused electrical stimulation (HIFES) muscle stimulation. This combination results in an overall aesthetic improvement of the submental area. The company unveiled the new applicator at a national sales meeting in January. “Unlike the cheek and […]
And the Winners Are…PeDRA Announces 2023 Grant Recipients
The Pediatric Dermatology Research Alliance (PeDRA) has awarded nearly $240K to support pediatric dermatology research across four competitive grant programs. Five investigators have received funding through the 2023 PeDRA Research Grants, Career Bridge Research Grant, Pediatric Alopecia Areata Challenge Grant, and Childhood Eczema Challenge Grant programs. The 2023 PeDRA Research Grant recipients are: Joyce Teng, MD, […]
National Rosacea Society Introduces New Seal of Acceptance for Skin Care Products
The National Rosacea Society (NRS) has launched a new Seal of Acceptance for skin care and cosmetic products cosmetic products. “One of the most common requests the NRS receives from rosacea patients is for information and advice about which skin care and cosmetic products are appropriate to use,” says Andrew Huff, President and Executive Director […]
New Insights on the Molecular Drivers of IL-23 Blockade in Psoriasis
A high-resolution spatial and transcriptomic atlas of IL-23 blockade in skin provides new insights on treatment response and resistance in psoriasis patients. Psoriasis vulgaris and other chronic inflammatory diseases improve markedly with therapeutic blockade of IL-23 signaling, but the genetic mechanisms underlying clinical responses remain poorly understood. The study, which was led by Enable Medicine […]
News You Can Use: Verrica Receives Permanent J-Code for YCANTH
The Centers for Medicare & Medicaid Services (CMS) has issued a permanent J-Code (J7354) for Verrica’s YCANTH, a molluscum contagiosum treatment. Under the Healthcare Common Procedure Coding System (HCPCS) process, the J-Code for YCANTH will become fully published April 1, 2024. “By securing a permanent J-Code for YCANTH, we have successfully reached a critical milestone in our […]
PsO Far, PsO Good for Can-Fite’s Oral A3 Adenosine Receptor Agonist
Oral piclidenoson continues to show efficacy and safety in psoriasis, according to the first Phase 3 data which appears in the Journal of the European Academy of Dermatology and Venereology. Can-Fite’s piclidenoson is a novel, first-in-class, A3 adenosine receptor agonist (A3AR) small molecule, orally bioavailable drug that has shown efficacy in Phase II and III psoriasis […]
Arcutis’ Roflumilast Foam Continues to Impress in Seb Derm
Roflumilast foam, 0.3% (Zoryve, Arcutis) bests vehicle in the treatment of seborrheic dermatitis, with 80% of individuals achieving Investigator Global Assessment (IGA) success and 51% of individuals reaching complete clearance at Week 8, according to new research published in the February 2024 issue of the Journal of American Academy of Dermatology. Zoryve foam was approved by […]